PRDM16 and fatty liver disease: In addition, adipocyte-specific deletion of PRDM16 inhibited beige adipocyte function in subcutaneous fat and promoted obesity, as well as aggravated insulin resistance and hepatic steatosis in mice under HFD, while caused minimal effects on brown fat (49).